Regulation, Reimbursement Notes From Indonesia
This article was originally published in PharmAsia News
Executive Summary
Indonesia sees a spurt in the use of generic drugs as the spread of national health insurance deepens demand. But policy makers remain concerned about the access to affordable medicines.